Gates Package — page 662
of 1375 pages
← p.661 p.663 → · this page in the original PDF · package
Rakai Health Sciences Program [US]
Pending
Rockefeller University
Pending
RNAceuticals, Inc.
Pending
Sanofi U.S. Services Inc.
Pending
SIGA Technologies, Inc
Pending
Simon Fraser University [CA]
Pending
Springer Nature Switzerland AG [Switzerand]
Pending
ViiV Healthcare UK (No.6) Ltd [GB]
Pending
Viro-Gen LTD.
Pending
Western University
Pending
Yale University
Pending
A.C. Camargo Cancer Center
AbbVie Inc.
Adamas Pharmaceuticals, Inc
American Gene Technologies International, Inc
Arbutus Biopharma Corporation [Canada]
AstraZeneca Pharmaceuticals LP
Bavarian Nordic A/S [Denmark]
Baxalta US, Inc
Beneficia Portuguesa de Sao Paulo [Brazil]
Beth Israel Deaconess Medical Center (BIDMC)
Bill & Melinda Gates Foundation (BMGF)
BIOLEGEND
Bioverativ (f.k.a. True North Therapeutics)
Brii Biosciences (Beijing) Co Ltd [China]
Bristol-Myers Squibb Company (BMS)
California Institute for Regenerative Medicine (CIRM)
Celgene Corporation
Cerus Corporation
Charles River Laboratories, Inc.
Columbia University
Columbia University Irving Medical Center
Crucell Vaccines Institute
CSL Behring
Dartmouth College
District of Columbia Department of Health (DC DOH)
Eli Lilly and Company
Elsevier
EMD Serono Research & Development Institute
Emergent BioSolutions Canada Inc. [Canada]
Emergent BioSolutions Inc.
Emory University
Excision Biotherapeutics
5/10/2022
10/9/2024
Active
1/29/2023
Active
Active
Active
Active
5/10/2022
Active
12/31/2023
11/14/2022
2/17/2022
Active
Active
Active
Active
Active
9/29/2023
Active
11/9/2021
Active
Active
2/11/2026
Active
Active
Active
Active
3/18/2022
Active
5/9/2024
2/22/2026
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/662
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00223 | — | attachment | 662 |